Stock listing
TSXV:COV Covalon Technologies Ltd. Stock
Home listing (TSXV) of Covalon Technologies Ltd.
Follow Covalon Technologies Ltd. into a list and get an email when it puts out news.
Share price · TSXV:COV
$3.70 CAD -0.05 (-1.3%)
Close on Nov 20, 2026
- Day range
- $3.70 – $3.73 CADNov 20, 2026
- Volume
- 33,314 sharesNov 20, 2026
- Market cap
- $102.2M CADAt the close on Nov 20, 2026 · price × 27.62M shares outstanding
- 52-week range
- $1.55 – $4.59 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $113,326 CADMedian day 17,443 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:COV · Home | $3.70 CAD | -0.05 (-1.3%) | 33,314 | $3.71 | $3.73 | $3.70 | $3.75 | Close on Nov 20, 2026 |
| OTC:CVALF | $2.61 USD | +0.01 (+0.4%) | 3,500 | $2.62 | $2.64 | $2.59 | $2.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSXV:COV · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.70 | -0.05 | -1.3% | $3.71 | $3.73 | $3.70 | 33,314 | |
| $3.75 | -0.15 | -3.8% | $3.80 | $3.80 | $3.69 | 11,352 | |
| $3.90 | -0.32 | -7.6% | $4.06 | $4.06 | $3.79 | 20,734 | |
| $4.22 | +0.01 | +0.2% | $4.20 | $4.28 | $4.15 | 15,218 | |
| $4.21 | +0.04 | +1.0% | $4.23 | $4.29 | $4.18 | 5,550 | |
| $4.17 | -0.09 | -2.1% | $4.21 | $4.21 | $4.16 | 4,007 | |
| $4.26 | -0.13 | -3.0% | $4.32 | $4.32 | $4.20 | 10,495 | |
| $4.39 | -0.04 | -0.9% | $4.46 | $4.53 | $4.35 | 14,803 | |
| $4.43 | +0.12 | +2.8% | $4.31 | $4.45 | $4.25 | 18,185 | |
| $4.31 | +0.27 | +6.7% | $4.10 | $4.31 | $4.05 | 46,086 | |
| $4.04 | -0.22 | -5.2% | $4.33 | $4.33 | $3.95 | 17,685 | |
| $4.26 | -0.11 | -2.5% | $4.39 | $4.39 | $4.19 | 24,650 | |
| $4.37 | -0.17 | -3.7% | $4.53 | $4.53 | $4.37 | 8,210 | |
| $4.54 | +0.11 | +2.5% | $4.45 | $4.57 | $4.40 | 46,968 | |
| $4.43 | -0.03 | -0.7% | $4.45 | $4.45 | $4.37 | 7,553 | |
| $4.46 | -0.04 | -0.9% | $4.50 | $4.50 | $4.46 | 8,035 | |
| $4.50 | +0.11 | +2.5% | $4.40 | $4.50 | $4.39 | 17,792 | |
| $4.39 | +0.17 | +4.0% | $4.29 | $4.50 | $4.29 | 41,380 | |
| $4.22 | +0.09 | +2.2% | $4.19 | $4.27 | $4.19 | 6,230 | |
| $4.13 | +0.13 | +3.2% | $4.19 | $4.20 | $4.03 | 10,847 | |
| $4.00 | -0.17 | -4.1% | $3.89 | $4.02 | $3.89 | 3,272 | |
| $4.17 | -0.16 | -3.7% | $4.32 | $4.32 | $4.14 | 8,149 | |
| $4.33 | +0.41 | +10.5% | $3.85 | $4.36 | $3.85 | 11,237 | |
| $3.92 | -0.11 | -2.7% | $4.03 | $4.09 | $3.90 | 15,523 | |
| $4.03 | -0.01 | -0.2% | $4.05 | $4.05 | $4.00 | 28,200 | |
| $4.04 | +0.10 | +2.5% | $4.05 | $4.08 | $4.01 | 3,200 | |
| $3.94 | -0.13 | -3.2% | $4.06 | $4.07 | $3.94 | 9,600 | |
| $4.07 | +0.10 | +2.5% | $4.23 | $4.23 | $3.98 | 41,000 | |
| $3.97 | -0.02 | -0.5% | $3.97 | $4.04 | $3.95 | 35,100 | |
| $3.99 | +0.17 | +4.5% | $3.82 | $3.99 | $3.82 | 1,400 | |
| $3.82 | -0.23 | -5.7% | $4.11 | $4.11 | $3.82 | 14,800 | |
| $4.05 | -0.29 | -6.7% | $4.31 | $4.31 | $4.02 | 31,100 | |
| $4.34 | +0.36 | +9.0% | $4.07 | $4.47 | $3.98 | 85,200 | |
| $3.98 | +0.10 | +2.6% | $3.90 | $4.09 | $3.75 | 7,400 | |
| $3.88 | +0.31 | +8.7% | $3.69 | $3.88 | $3.65 | 6,500 | |
| $3.57 | -0.65 | -15.4% | $4.21 | $4.21 | $3.57 | 62,800 | |
| $4.22 | -0.34 | -7.5% | $4.59 | $4.59 | $4.07 | 52,100 | |
| $4.56 | +0.32 | +7.5% | $4.22 | $4.56 | $4.22 | 106,700 | |
| $4.24 | +0.17 | +4.2% | $4.14 | $4.24 | $4.11 | 49,800 | |
| $4.07 | +0.01 | +0.2% | $4.10 | $4.14 | $4.00 | 28,400 | |
| $4.06 | +0.09 | +2.3% | $4.00 | $4.10 | $3.94 | 56,300 | |
| $3.97 | -0.02 | -0.5% | $3.76 | $3.99 | $3.76 | 17,200 | |
| $3.99 | +0.29 | +7.8% | $3.85 | $4.01 | $3.85 | 93,100 | |
| $3.70 | 0.00 | 0.0% | $3.74 | $3.74 | $3.61 | 9,500 | |
| $3.70 | +0.15 | +4.2% | $3.58 | $3.75 | $3.57 | 49,500 | |
| $3.55 | +0.09 | +2.6% | $3.55 | $3.62 | $3.54 | 30,300 | |
| $3.46 | -0.14 | -3.9% | $3.64 | $3.64 | $3.46 | 9,100 | |
| $3.60 | +0.30 | +9.1% | $3.31 | $3.62 | $3.31 | 67,200 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.36 | $3.30 | 12,000 | |
| $3.30 | -0.07 | -2.1% | $3.36 | $3.36 | $3.30 | 12,300 | |
| $3.37 | -0.17 | -4.8% | $3.59 | $3.59 | $3.36 | 18,800 | |
| $3.54 | +0.24 | +7.3% | $3.32 | $3.55 | $3.32 | 101,000 | |
| $3.30 | +0.25 | +8.2% | $3.07 | $3.30 | $3.06 | 152,300 | |
| $3.05 | +0.05 | +1.7% | $2.97 | $3.06 | $2.97 | 10,000 | |
| $3.00 | 0.00 | 0.0% | $3.04 | $3.04 | $2.96 | 6,200 | |
| $3.00 | -0.02 | -0.7% | $3.04 | $3.04 | $2.97 | 20,900 | |
| $3.02 | +0.07 | +2.4% | $2.95 | $3.09 | $2.95 | 71,100 | |
| $2.95 | +0.02 | +0.7% | $2.93 | $2.95 | $2.89 | 23,500 | |
| $2.93 | +0.64 | +27.9% | $2.82 | $3.00 | $2.81 | 153,600 | |
| $2.29 | -0.02 | -0.9% | $2.30 | $2.31 | $2.29 | 7,800 | |
| $2.31 | 0.00 | 0.0% | $2.31 | $2.31 | $2.31 | 600 | |
| $2.31 | +0.01 | +0.4% | $2.31 | $2.31 | $2.31 | 600 | |
| $2.30 | -0.03 | -1.3% | $2.33 | $2.36 | $2.30 | 3,600 | |
| $2.33 | +0.08 | +3.6% | $2.25 | $2.33 | $2.21 | 18,100 |
Splits
1 split · TSXV:COV · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- TSXV:COV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Oct 27, 2026
Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference
Latest earnings call · Aug 27, 2026
Covalon Technologies (TSXV:COV) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 27, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference
Oct 27, 2026
Closed $4.50 (+2.5%) on Oct 28, 2026
Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting
Sep 28, 2026
Closed $4.56 (+7.5%) on Sep 28, 2026
Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
Sep 24, 2026
Closed $4.07 (+0.2%) on Sep 24, 2026
Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
Sep 22, 2026
Closed $3.97 (-0.5%) on Sep 22, 2026
Covalon Reports Fiscal 2026 Third Quarter Results
Aug 27, 2026
Closed $2.93 (+27.9%) on Aug 27, 2026
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
Aug 20, 2026
Closed $2.33 (+3.6%) on Aug 20, 2026
Covalon Announces Appointment of New Director and DSU Grants
Jun 9, 2026
Closed $2.15 (-0.5%) on Jun 9, 2026
Covalon Reports 2026 Second Quarter Results
May 21, 2026
Closed $2.00 (-3.8%) on May 21, 2026
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results
May 14, 2026
Closed $1.95 (-0.5%) on May 14, 2026
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
Apr 15, 2026
Closed $1.98 (0.0%) on Apr 16, 2026
Covalon Technologies Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 19 in the last 12 months · 171 in all · newest Oct 27, 2026 · oldest 2005
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 27, 2026
- Decks
- 28 decks · latest Aug 27, 2026
Where Covalon Technologies Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:COV · Home listing · This page | TSXV | Canada | CAD |
| OTC:CVALF | OTC | United States | USD |
| Cboe Canada:COV | Cboe Canada | Canada | CAD |
Valuation
P/E 23.3× against a median of 13.9×: 7th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $82.80M CAD
- P/E
- 23.3×
- EV/sales
- 2.4×
- EV/EBITDA
- 16.8×
- Price/book
- 3.2×
- Gross margin
- 59.9%
- Operating margin
- 11.5%
- Net margin
- 12.8%
- Debt to equity
- 0.0×
- Beta vs S&P/TSX Composite
- 0.60
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Covalon Technologies Ltd. · TSXV:COV | US$71.26M | US$57.74M | 23.3× | 2.4× | 16.8× | 3.2× | 12.8% | 0.0× | 0.60 |
| SkinHealth Systems Inc. · NASDAQ:SKIN | US$77.00M | US$228.9M | n/a | 0.8× | 8.0× | 1.4× | −6.3% | 4.7× | 1.24 |
| Graphy Inc. · KRX:318060 | US$76.80M | US$76.08M | n/a | 4.4× | n/a | 6.8× | −48.1% | 0.0× | n/a |
| L&K BIOMED Co., Ltd. · KRX:156100 | US$76.55M | US$61.13M | 37.3× | 2.1× | 24.3× | 1.6× | 6.9% | 0.0× | n/a |
| Wellell Inc. · TWSE:4106 | US$73.78M | US$52.11M | 13.1× | 0.7× | 5.4× | 1.0× | 7.4% | 0.1× | n/a |
| A Plus Biotechnology Co Ltd · TWSE:6918 | US$73.07M | US$63.19M | 13.0× | 2.4× | 8.6× | 2.0× | 20.9% | 0.1× | n/a |
| C-Rad AB Class B · OMXSTO:CRAD_B | US$72.97M | US$59.62M | 15.7× | 1.5× | 9.1× | 2.0× | 11.4% | 0.0× | n/a |
| CG MedTech Co.Ltd. · KRX:056090 | US$71.34M | US$72.81M | 14.7× | 1.9× | 20.1× | 1.0× | 12.8% | 0.1× | n/a |
| Sewoonmedical Co., Ltd. · KRX:100700 | US$70.11M | −US$3.91M | 6.8× | −0.1× | −0.3× | 0.6× | 20.9% | 0.0× | n/a |
| MITECH Co., Ltd. · KRX:179290 | US$69.97M | US$21.09M | 4.6× | 0.4× | 1.2× | 0.7× | 30.3% | 0.0× | n/a |
| Nexstim PLC · OMXHEX:NXTMH | US$67.09M | US$64.72M | 107× | 5.4× | 34.6× | 7.2× | 5.2% | 0.4× | n/a |
| Median of the others | US$73.02M | US$62.16M | 13.9× | 1.7× | 8.6× | 1.5× | 9.4% | 0.1× | 1.24 |
Forecasts
Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 4.70 CAD · Analysts' mean
- EPS, year to Sep 2026
- 0.17 · 1 analyst
- Revenue, year to Sep 2026
- 35.77M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Brent Ashton | Chief Executive Officer and Director, Covalon Technologies Ltd. |
| Katie Martinovich | Chief Financial Officer |
| Kim Crooks | Chief Operating Officer and Director, Covalon Technologies Ltd. |
| Martin Goldfarb | Director, Covalon Technologies Ltd. |
| Murray Miller | Director, Covalon Technologies Ltd. |
| Samantha Nutt | Director, Covalon Technologies Ltd. |
| Val DiTizio | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| Abe Schwartz | Chair |
| Brent Ashton | Chief Executive Officer and Director, Covalon Technologies Ltd. |
| Joseph Cordiano | Lead Director, Covalon Technologies Ltd. |
| Kim Crooks | Chief Operating Officer and Director, Covalon Technologies Ltd. |
| Ron Smith | Director |
Events
- Next results
- Dec 17, 2026 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Covalon Technologies (TSXV:COV) Q3 2026 Earnings Call | Thu, Aug 27, 2026 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2026 Earnings Call | Thu, May 21, 2026 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q1 2026 Earnings Call | Wed, Feb 25, 2026 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q4 2025 Earnings Call | Thu, Dec 11, 2025 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q3 2025 Earnings Call | Thu, Aug 21, 2025 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2025 Earnings Call | Wed, May 28, 2025 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q1 2025 Earnings Call | Fri, Feb 21, 2025 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q4 2024 Earnings Call | Tue, Jan 07, 2025 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q3 2024 Earnings Call | Wed, Aug 21, 2024 · 8:30 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2024 Earnings Call | Wed, May 29, 2024 · 8:15 AM ET | Replay |
All 20 calls
| Call | When | Status |
|---|---|---|
| Covalon Technologies (TSXV:COV) Q3 2023 Earnings Call | Wed, Aug 16, 2023 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2023 Earnings Call | Thu, May 25, 2023 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q1 2023 Earnings Call | Thu, Feb 23, 2023 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q4 2022 Earnings Call | Thu, Jan 26, 2023 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q3 2022 Earnings Call | Mon, Aug 29, 2022 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2022 Earnings Call | Mon, May 30, 2022 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q1 2022 Earnings Call | Tue, Mar 01, 2022 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q4 2021 Earnings Call | Mon, Dec 13, 2021 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q3 2021 Earnings Call | Mon, Aug 30, 2021 · 9:00 AM ET | Replay |
| Covalon Technologies (TSXV:COV) Q2 2021 Earnings Call | Mon, May 31, 2021 · 9:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Aug 27, 2026 · Before open | +27.9% |
| Q2 2026 | May 21, 2026 · Before open | −3.9% |
| Q1 2026 | Feb 25, 2026 · Before open | +13.0% |
| Q4 2025 | Dec 11, 2025 · Before open | −6.6% |
| Q3 2025 | Aug 21, 2025 · Before open | −16.7% |
| Q2 2025 | May 28, 2025 · Before open | −8.2% |
| Q1 2025 | Feb 21, 2025 · Before open | −11.9% |
| Q3 2023 | Aug 16, 2023 · Before open | 0.0% |
| Q2 2023 | May 25, 2023 · Before open | +9.7% |
| Q1 2023 | Feb 22, 2023 · After close | +4.5% |
All 18 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Dec 31, 2022 · Before open | +2.1% |
| Q3 2022 | Aug 29, 2022 · Before open | −7.7% |
| Q2 2022 | May 30, 2022 · Before open | +3.8% |
| Q1 2022 | Mar 1, 2022 · Before open | +6.3% |
| Q4 2021 | Dec 13, 2021 · Before open | 0.0% |
| Quarter to Jun 30, 2021 | Aug 30, 2021 · Before open | +9.6% |
| Quarter to Mar 31, 2021 | May 31, 2021 · Before open | +10.3% |
| Quarter to Dec 31, 2020 | Mar 1, 2021 · Before open | −3.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Aug 27, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 14 slides | May 21, 2026 |
| Shareholder Meeting (March 2026) | Shareholder meeting | 11 slides | Mar 25, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 11 slides | Feb 25, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 15 slides | Dec 11, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 18 slides | Aug 21, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 15 slides | May 28, 2025 |
| Shareholder Meeting (March 2025) | Shareholder meeting | 24 slides | Mar 19, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 13 slides | Feb 21, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 17 slides | Jan 7, 2025 |
All 28 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Planet MicroCap Showcase: VANCOUVER 2024 | Conference | 21 slides | Sep 26, 2024 |
| Q3 2024 Earnings Presentation | Earnings | 13 slides | Aug 21, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 12 slides | May 29, 2024 |
| Shareholder Meeting (March 2024) | Shareholder meeting | 17 slides | Mar 6, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 17 slides | Aug 16, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 17 slides | May 25, 2023 |
| Planet MicroCap Showcase: VEGAS 2023 | Conference | 23 slides | Apr 26, 2023 |
| Shareholder Meeting (March 2023) | Shareholder meeting | 27 slides | Mar 8, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 16 slides | Feb 23, 2023 |
| Q4 2022 Earnings Presentation | Earnings | 17 slides | Jan 26, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 18 slides | Aug 29, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 19 slides | May 30, 2022 |
| Shareholder Meeting (March 2022) | Shareholder meeting | 29 slides | Mar 9, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 15 slides | March 2022 |
| Q4 2021 Earnings Presentation | Earnings | 18 slides | Dec 13, 2021 |
| SNN Network Canada Virtual Event (December 2021) | Conference | 30 slides | Dec 8, 2021 |
| Shareholder Meeting (June 2021) | Shareholder meeting | 24 slides | Jun 30, 2021 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 32 slides | Nov 12, 2020 |
Financials
Annual, in CAD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.8M | 31.2M | 26.6M | 18.1M | 19.6M | 25.8M | 34.0M | 26.7M | 27.3M | 6.71M |
| Cost of revenue | 15.3M | 12.2M | 12.2M | 10.7M | 9.86M | 13.3M | 12.2M | 7.06M | 6.30M | 2.56M |
| Gross profit | 17.5M | 18.9M | 14.4M | 7.49M | 9.70M | 12.5M | 21.8M | 19.7M | 21.0M | 4.15M |
| Research and development | 1.32M | 1.59M | 1.37M | 1.10M | 1.14M | 794.2K | 1.36M | 1.42M | 1.13M | 762.8K |
| Selling, general and administrative | 12.4M | 7.78M | 7.40M | 6.96M | 4.80M | 8.64M | 11.8M | 6.45M | 5.16M | 3.57M |
| Operating income | 1.76M | 2.15M | -4.49M | -9.14M | 838.3K | -6.09M | -8.25M | 1.62M | 1.81M | -2.97M |
| Depreciation and amortization | 954.9K | 986.5K | 969.4K | 1.03M | 700.5K | 1.21M | 629.9K | 356.4K | 269.2K | 233.5K |
| EBITDA | 2.72M | 3.14M | -3.52M | -8.11M | 1.54M | -4.89M | -7.62M | 1.97M | 2.08M | -2.73M |
| Interest expense | 111.6K | 419.4K | 860.2K | 889.1K | 0 | 0 | 0 | |||
| Income before tax | 2.06M | 2.67M | -4.46M | -9.25M | 419.0K | -6.95M | -9.14M | 1.62M | 1.81M | -3.10M |
| Income tax | 801.5K | 409.3K | -23.1M | 999.8K | 458.0K | -2 | -21.5K | -35.0K | ||
| Net income | 2.06M | 2.67M | -4.46M | -9.66M | 23.5M | -6.95M | -9.14M | 1.62M | 1.81M | -3.10M |
| Earnings per share, basic | 0.08 | 0.11 | -0.18 | -0.38 | 0.91 | -0.27 | -0.41 | 0.07 | 0.09 | -0.26 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 17.4M | 16.7M | 8.79M | 14.1M | 22.9M | 3.51M | 9.58M | 5.48M | 4.16M | 1.45M |
| Short-term investments | 0 | |||||||||
| Receivables | 5.84M | 3.91M | 6.16M | 4.73M | 6.40M | 3.33M | 3.64M | 5.13M | 2.75M | 614.6K |
| Inventory | 7.40M | 7.70M | 5.94M | 4.97M | 4.70M | 7.20M | 8.47M | 5.56M | 2.48M | 2.04M |
| Current assets | 31.5M | 29.0M | 21.3M | 27.2M | 37.4M | 14.8M | 22.4M | 17.1M | 9.78M | 4.28M |
| Property, plant and equipment | 1.87M | 2.11M | 4.64M | 1.89M | 1.16M | 615.8K | 454.0K | |||
| Goodwill | 13.0M | 12.9M | ||||||||
| Total assets | 36.1M | 31.8M | 24.9M | 30.4M | 40.6M | 34.7M | 39.6M | 19.7M | 12.0M | 6.49M |
| Accounts payable | 4.46M | 3.72M | 4.04M | 3.90M | 5.68M | 4.72M | 2.34M | 1.69M | ||
| Current liabilities | 3.77M | 4.00M | 5.19M | 4.54M | 5.00M | 22.6M | 17.9M | 6.46M | 2.80M | 2.12M |
| Long-term debt | 6.29M | |||||||||
| Total debt | 901.7K | 1.56M | 2.17M | 2.59M | 20.9M | 18.1M | 1.53M | |||
| Total liabilities | 5.40M | 4.30M | 6.11M | 6.15M | 7.21M | 25.6M | 24.7M | 6.58M | 2.99M | 2.68M |
| Shareholders' equity | 30.7M | 27.5M | 18.8M | 24.2M | 33.4M | 9.11M | 14.9M | 13.1M | 8.98M | 3.81M |
| Shares outstanding | 27.4M | 24.3M | 24.9M | 25.8M | 25.8M | 25.8M | 22.5M | 23.1M | 20.0M | 11.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.29M | 3.47M | -3.18M | -7.99M | 621.4K | -4.03M | -2.83M | -655.5K | 15.1K | -1.03M |
| Capital spending | -847.0K | -416.8K | -1.32M | -1.08M | -177.7K | -371.1K | -1.28M | -740.1K | -359.7K | -251.7K |
| Free cash flow | 1.44M | 3.06M | -4.50M | -9.08M | 443.7K | -4.40M | -4.11M | -1.40M | -344.6K | -1.28M |
| Cash from investing | 315.3K | 36.4M | -370.4K | -7.10M | -740.2K | -349.9K | 339.4K | |||
| Cash from financing | -529.3K | 4.97M | -2.16M | -2.19M | -8.25M | -1.75M | 14.0M | 2.42M | 3.19M | 893.5K |
| Dividends paid | -1.60M | 0 | 0 | 0 | ||||||
| Share buybacks | 0 | -1.47M | -1.73M | 0 | 3.19M | 893.5K | ||||
| Change in cash | 620.5K | 7.95M | -5.27M | -8.89M | 19.4M | -6.07M | 4.09M | 1.33M | 2.70M | 149.8K |
Cap table
Built by 6ix from Covalon Technologies Ltd.’s releases · as of Jun 30, 2026
- Common shares
- 27,618,077
- Fully diluted
- 27,640,299
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 27,618,077 | Jun 30, 2026 |
| Options and RSUs | 22,222 | Jun 9, 2026 |
Warrants and options
| Lot |
|---|
| DSUs · expire about Jun 2027 |
Share count over time
| Count | Shares |
|---|---|
| Jun 30, 2026 | 27,618,077 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Abe Schwartz | Chair · Since at least Sep 23, 2025 |
| Brent Ashton | Chief Executive Officer and Director, Covalon Technologies Ltd. · Since at least Sep 28, 2026 |
| Joseph Cordiano | Lead Director, Covalon Technologies Ltd. · Since at least Mar 26, 2026 |
| Katie Martinovich | Chief Financial Officer · Since at least Dec 11, 2025 |
| Kim Crooks | Chief Operating Officer and Director, Covalon Technologies Ltd. · Since at least May 15, 2025 |
| Martin Goldfarb | Director, Covalon Technologies Ltd. · Since at least Mar 26, 2026 |
| Murray Miller | Director, Covalon Technologies Ltd. · Since at least Jun 9, 2026 |
| Ron Smith | Director · Since at least Mar 26, 2026 |
| Samantha Nutt | Director, Covalon Technologies Ltd. · Since at least Mar 26, 2026 |
| Val DiTizio | Chief Scientific Officer · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Covalon Technologies Ltd.